ESMO 2022 - Opening Press Conference
Webcast with Q[&]A from ESMO 2022 Press BriefingПодробнее
![Webcast with Q[&]A from ESMO 2022 Press Briefing](https://img.youtube.com/vi/_AoR0WN9y7I/0.jpg)
ESMO 2022: “Un congresso che ricorderemo per molto tempo”Подробнее
2022 EHE 360 Patient Conference - Welcome, Introduction to ESMO Consensus PaperПодробнее
Josep Tabernero: What's ESMO doing to make "translating Science into better Ca-Patient Care" Pro...Подробнее
Emergence of antibody-drug conjugates in metastatic breast cancer: 2022 ESMO FloridaПодробнее
Oncoletter: ESMO 2024 Opening Press BriefingПодробнее
Prof Fortunato Ciardiello:Подробнее
ESMO Lung SymposiumПодробнее
Using genomic assays for clinical decision making in early breast cancer: 2022 ESMO FloridaПодробнее
#ESMO22 Highlights on first-line atezolizumab in NSCLC not eligible for platinum: The IPSOS studyПодробнее
“Moving the needle” in the metastatic breast cancer setting: 2022 ESMO FloridaПодробнее
ESMO 2022: Highlights, commentary and analysisПодробнее
ESMO 2022丨Interview with Professor Solange Peters: Sharing the Latest Research ProgressПодробнее
ESMO 2022 HighlightsПодробнее
Biomarkers and risk assessment in oligometatstatic disease: 2022 ESMO FloridaПодробнее
ESMO22 - first results of the RADICALS-HD trial (ISRCTN40814031)Подробнее
#ESMO22 Highlights on actionable inflammatory axis for air pollution induced NSCLCПодробнее
Novel targeted agents in lymphoma - “Not our old chemotherapy drugs”: 2022 ESMO FloridaПодробнее
Introductory Remarks - Susana Banerjee, LondonПодробнее
Precision oncology in GIST and the importance of mutational testing: 2022 ESMO FloridaПодробнее
